Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection

World Journal of Gastroenterology

Volumn 12, Issue 40, 2006, Pages 6453-6457

  Marangoni, Antonella ^a   Donati, Manuela ^a   Cavrini, Francesca ^a   Aldini, Rita ^a   Accardo, Silvia ^a   Sambri, Vittorio ^a   Montagnani, Marco ^a   Cevenini, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chlamydia pneumoniae; Culture isolation; Fluorescence in situ hybridization; Hepatocytes; Kupffer cells; Liver infection; Primary biliary cirrhosis; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BILIARY CIRRHOSIS; CELL SEPARATION; CELL STIMULATION; CELL STRAIN; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE IN SITU HYBRIDIZATION; HEPATITIS; IN VITRO STUDY; INNATE IMMUNITY; INOCULATION; KUPFFER CELL; LIVER CELL; LIVER HOMOGENATE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY;

EID: 33750989631     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i40.6453     Document Type: Article

References (37)

1. Grayston JT, Aldous MB, Easton A, Wang SP, Kuo CC, Campbell LA, Altman J. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168: 1231-1235
2. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996; 101: 508-515
3. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273-278
4. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, Szklo M. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med 1993; 95: 499-504
5. Grayston JT. Chlamydia pneumoniae (TWAR) infections in children. Pediatr Infect Dis J 1994; 13: 675-684; quiz 685
6. Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J Hepatol 2004; 40: 380-384
7. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273
8. Haydon GH, Neuberger J. PBC: an infectious disease? Gut 2000; 47: 586-588
9. Ljungh A, Nilsson HO, Wadstrom T, Stenram U, Willen R. Microbes as trigger for primary biliary cirrhosis and primary sclerosing cholangitis. Dig Liver Dis 2005; 37: 803-804
10. Yang ZP, Kuo CC, Grayston JT. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis 1995; 171: 736-738
11. Montigiani S, Falugi F, Scarselli M, Finco O, Petracca R, Galli G, Mariani M, Manetti R, Agnusdei M, Cevenini R, Donati M, Nogarotto R, Norais N, Garaguso I, Nuti S, Saletti G, Rosa D, Ratti G, Grandi G. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun 2002; 70: 368-379
12. Smedsrod B, Pertoft H. Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence. J Leukoc Biol 1985; 38: 213-230
13. Sambri V, Aldini R, Massaria F, Montagnani M, Casanova S, Cevenini R. Uptake and killing of Lyme disease and relapsing fever borreliae in the perfused rat liver and by isolated Kupffer cells. Infect Immun 1996; 64: 1858-1861
14. Marangoni A, Aldini R, Sambri V, Montagnani M, Ballardini G, Storni E, Cevenini R. Uptake and killing of Leptospira interrogans and Borrelia burgdorferi, spirochetes pathogenic to humans, by reticuloendothelial cells in perfused rat liver. Infect Immun 2000; 68: 5408-5411
15. Poppert S, Essig A, Marre R, Wagner M, Horn M. Detection and differentiation of chlamydiae by fluorescence in situ hybridization. Appl Environ Microbiol 2002; 68: 4081-4089
16. Jacobs DM. Structural features of binding of lipopolysaccharides to murine lymphocytes. Rev Infect Dis 1984; 6: 501-505
17. Fields KA, Hackstadt T. The chlamydial inclusion: escape from the endocytic pathway. Annu Rev Cell Dev Biol 2002; 18: 221-245
18. Siscovick DS, Schwartz SM, Caps M, Wang SP, Grayston JT. Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology. J Infect Dis 2000; 181 Suppl 3: S417-S420
19. Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, Wang SP, Psaty BM, Tracy RP, Kuller LH, Kronmal RA. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study. Circulation 2000; 102: 2335-2340
20. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995; 92: 6911-6914
21. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-849
22. Puolakkainen M, Campbell LA, Kuo CC, Leinonen M, Gronhagen-Risks C, Saikku P. Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J Infect 1996; 33: 199-205
23. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997; 35: 48-52
24. Sambri V, Donati M, Storni E, Di Leo K, Agnusdei M, Petracca R, Finco O, Grandi G, Ratti G, Cevenini R. Experimental infection by Chlamydia pneumoniae in the hamster. Vaccine 2004; 22: 1131-1137
25. Liu HY, Deng AM, Zhang J, Zhou Y, Yao DK, Tu XQ, Fan LY, Zhong RQ. Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis. World J Gastroenterol 2005; 11: 4108-4110
26. Vazquez-Torres A, Vallance BA, Bergman MA, Finlay BB, Cookson BT, Jones-Carson J, Fang FC. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol 2004; 172: 6202-6208
27. el Hag IA, Hashim FA, el Toum IA, Homeida M, el Kalifa M, el Hassan AM. Liver morphology and function in visceral leishmaniasis (Kala-azar). J Clin Pathol 1994; 47: 547-551
28. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun 2002; 70: 2741-2751
29. Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis 2003; 7: 759-777, vi
30. Ishibashi H, Nakamura M, Shimoda S, Gershwin ME. T cell immunity and primary biliary cirrhosis. Autoimmun Rev 2003; 2: 19-24
31. Tanaka A, Prindiville TP, Gish R, Solnick JV, Coppel RL, Keeffe EB, Ansari A, Gershwin ME. Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol 1999; 31: 664-671
32. Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A, Van de Water J, Gershwin ME, Garry RF. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998; 351: 1620-1624
33. Morshed SA, Nishioka M, Saito I, Komiyama K, Moro I. Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients. Gastroenterol Jpn 1992; 27: 751-758
34. Harada K, Tsuneyama K, Sudo Y, Masuda S, Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation? Hepatology 2001; 33: 530-536
35. Hopf U, Moller B, Stemerowicz R, Lobeck H, Rodloff A, Freudenberg M, Galanos C, Huhn D. Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 1989; 2: 1419-1422
36. O'Donohue J, Fidler H, Garcia-Barcelo M, Nouri-Aria K, Williams R, McFadden J. Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis. J Hepatol 1998; 28: 433-438
37. Mao TK, Lian ZX, Selmi C, Ichiki Y, Ashwood P, Ansari AA, Coppel RL, Shimoda S, Ishibashi H, Gershwin ME. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 2005; 42: 802-808